SearchDictionaryMobileLogin

triflusal

56  relevant articles (7 outcomes, 20 trials/studies) found for this Bio-Agent

Description: inhibits platelet aggregation similarly to aspirin; structure

Also Known As:
2-acetoxy-4-trifluoromethylbenzoic acid; Disgren; Hormona brand of triflusal; Uriach brand of triflusal; 2- (acetyloxy)-4-(trifluoromethyl)benzoic acid

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cechetto, David F: 2 articles (02/2007 - 08/2005)
2. Cheng, Guanliang: 2 articles (02/2007 - 08/2005)
3. Campos, Vicente: 2 articles (05/2005 - 06/2003)
4. Muñoz, Genís: 2 articles (05/2005 - 06/2003)
5. Navas, Carlos: 2 articles (05/2005 - 01/2002)
6. Ureña, I M: 2 articles (01/2005 - 06/2004)
7. Arrebola, M M: 2 articles (01/2005 - 06/2004)
8. De La Cruz, J P: 2 articles (01/2005 - 06/2004)
9. Ruiz-Villafranca, D: 2 articles (01/2005 - 06/2004)
10. González-Correa, J A: 2 articles (01/2005 - 06/2004)

Related Diseases

1. Stroke (Strokes)
2. Atrial Fibrillation
3. Cerebral Infarction
4. Body Weight (Weight, Body)
06/01/1990 - "The study of the prevention of platelet thrombi formation on these materials was carried out in 6 groups of 8 animals: group 1 (control), group 2 (5 mg/kg body weight/day acetylsalicylic acid), group 3 (20 mg/kg body weight/day acetylsalicylic acid), group 4 (15 mg/kg body wt/day triflusal plus 5 mg/kg body wt/day dipyridamole), group 5 (15 mg/kg body wt/day triflusal) and group 6 (5 mg/kg body wt/day acetylsalicylic acid plus 5 mg/kg body wt/day dipyridamole)"
10/01/1989 - "Groups of 7 mongrel dogs received treatment for 7 days prior to the trial: group I, control; group II, 5 mg/kg body weight/day acetylsalicylic acid; group III, 20 mg/kg body weight/day acetylsalicylic acid; group IV, 15 mg/kg body weight/day triflusal + 5 mg/kg body weight/day dipyridamole; group V, 15 mg/kg body weight/day triflusal; and group VI, 5 mg/kg body weight/day acetylsalicylic acid + 5 mg/kg body weight/day dipyridamole"
05/01/1989 - "Groups of 7 mongrel dogs received treatment for 7 days prior to the trial: Group I, control; Group II, 5 mg/kg body weight/day acetylsalicylic acid; Group III, 20 mg/kg body wt/day acetylsalicylic acid; Group IV, 15 mg/kg body wt/day triflusal + 5 mg/kg body wt/day dipyridamole; Group V, 15 mg/kg body wt/day triflusal; and Group VI, 5 mg/kg body wt/day acetylsalicylic acid + 5 mg/kg body wt/day dipyridamole"
04/01/2006 - "Assessment of the effects of triflusal in pressure overload-induced cardiac hypertrophy by aortic banding resulted in a significant reduction in the ratio of heart weight to body weight and in a reduction of the mRNA levels of the cardiac hypertrophy markers ANF and alpha-actinin compared with untreated banded rats"
Order ALL the reference details at left...
5. Transient Ischemic Attack

Related Drugs and Biologics

1. Aspirin (Acetylsalicylic Acid)
2. Dipyridamole (Persantine)
3. Ticlopidine (Ticlid)